The NCI solved the LYMErix Crime in 2003, and SmithKline admitted to it in 1998.

[Kathleen]

To: kathleen...@hhs.gov, francis...@nih.hhs.gov,
margaret...@fda.hhs.gov, dwh...@forbes.com,
ca...@drcarolgoodheart.com, lPick...@cdc.gov, Durlan...@yale.edu,
Aa...@columbia.edu, gary_w...@nymc.edu,
scientifi...@ostp.gov, pkru...@princeton.edu,
Stanle...@fiu.edu, margaret...@hhs.fds.gov,
emcsw...@niaid.nih.gov, afa...@niaid.nih.gov,
Spin...@yahoogroups.com, kshe...@calea.org, fit...@gmail.com,
patrick.f...@usdoj.gov, model...@sbcglobal.net,
jdr...@nejm.org, let...@courant.com, Jgerb...@cdc.gov,
michae...@ct.gov, con...@po.state.ct.us, executive-
edi...@nytimes.com, managin...@nytimes.com, news-
ti...@nytimes.com, biz...@nytimes.com, for...@nytimes.com,
nati...@nytimes.com, dv...@cdc.gov, brigidc...@optonline.net,
tr...@hotmail.com, illino...@aol.com, jle...@courant.com,
tinaj...@yahoo.com, jhorn...@fff.org, thomas...@usdoj.gov,
thoma...@ct.gov, kur...@washpost.com, georg...@washpost.com,
p...@allegorypress.com, commissi...@po.state.ct.us,
brans...@comcast.net, vts...@comcast.net, o...@po.state.ct.us,
freet...@charter.net, scott....@po.state.ct.us,
govern...@po.state.ct.us, attorney...@ct.gov,
randall...@usdoj.gov, Robert....@yale.edu, editor@greenwich-
post.com, harol...@yale.edu, sedm...@nswbc.org, rrmcg...@aol.com,
fr...@nytimes.com, saint....@sbcglobal.net
Cc: fra...@ucia.gov, dr-ahma...@president.ir,
eugener...@washpost.com, bmi...@newstimes.com, tr...@hotmail.com,
rast...@aol.com, billc...@gmail.com, amcg...@rms-law.com,
rjmu...@aol.com, paulcrai...@yahoo.com,
criminal...@usdoj.gov, karla.d...@usdoj.gov,
christophe...@usdoj.gov, richar...@yale.edu,
harol...@yale.edu, james.p...@yale.edu, inq...@aldf.com,
ly...@idsociety.org, meganm...@theatlantic.com

Subject: The NCI solved the LYMErix Crime in 2003, and SmithKline
admitted to it in 1998.

Date: Oct 12, 2011 4:48 AM

http://www.actionlyme.org

The following is the NIH explaining how Lyme/LYMErix Disease/and
IDSA's and Yale's "New Great Imitators" occur; 1) Immunosuppression
from the chronic agonism of TLR2 by Pam3Cys (or OspA or Yale's Lyme
vaccine, LYMErix), 2) the activation of viruses like Epstein-Barr, 3)
tolerance to subsequent fungal (mycoplasmal) infections in the blood,
causing chronic fatigue, and aids the development of the likes of
Staph aureus as "antibiotic resistant":

"This process, which was initially termed "endotoxin tolerance",
refers to the induction of a hyporesponsive state in macrophages
following primary exposure to microbial ligands such as
lipopolysaccharide (LPS), bacterial lipoprotein, lipoteichoic acid,
and oligo CpG–DNA, now known to signal through TLRs. The resulting
tolerant state is associated with a marked decrease in proinflammatory
cytokine production following secondary challenge with these ligands
[111213 ]."
http://www.jleukbio.org/content/75/3/460.long


This information is 8 years old, so we all may wonder why we're still
fighting IDSA and their crazy "guidelines." 'Besides the fact that
MDs aren't scientists and are brainwashed out of any capacity they
ever had for independent thought.

If the autovaccination (blebbing) by Lyme spirochetes turns off the
immune response to subsequent TLR2 agonist challenge as described
above by the NIH, then obviously the diagnostic standard (CDC's "case
definition" or "two-tiered" standard) for "Lyme Disease" cannot be
used for anyone who has been sick longer than 2-3 months.

And it also means Klempner's "Long Term Treatment Study of Chronic
Lyme" can be thrown in the garbage, since that's based on the Dearborn
"case" criteria.
http://www.actionlyme.org/MKLEMPNER.htm

And this is all not to mention the fact that we're talking activated
Epstein-Barr and relapsed patients are fighting fatigue from
mycoplasma - to which they're tolerant, now, and which will simply
grow back - in
http://www.actionlyme.org/101016.htm
the blood. Antibiotics won't work for a damaged immune system and
Epstein-Barr. And as far as mycoplasma and activated common viruses
like herpesviruses in the blood, organs and brain.... well, there's
your variety show of symptoms AKA New Great Imitator.
http://www.actionlyme.org/CHP_9_IDSA_REVIEWS.htm

None of these infections will be detectable with antibodies. Perhaps
that was Kaiser-Permanente's plan all along for whacking people with
LYMErix: "No antibodies, no treatment."
http://www.actionlyme.org/CRYME_DISEASE.htm

BTW - I only just read that report just now, the whole way through, or
I would have included it in our Pam3Cys Powerpoint presentation. It
was about HIV, which, you know, the lack of scientific progress in
that area dominated US Medicine/the NIH. It turns out, had Yale told
the truth about LYMErix' "safety and efficacy," the whole world would
have learned about all of this sooner and Yale and UConn wouldn't
suffer the humiliation of being unfunded pariahs who have nothing to
look forward to except being a ""Mouse Factory."

======

BEN LUFT AND SMITHKLINE'S DENNIS PARENTI
AT THE 1998 FDA LYMERIX MEETING ADMITTING
TO LYME AND LYMERIX BEING THE SAME DISEASE:

BEN LUFT and SmithKline's Dennis Parenti at the 1998 FDA Vaccine
Meeting on LYMErix saying "LYMErix-Disease was the same as Lyme
Disease," and that "you can't use the Dearborn diagnostic standard to
diagnose Lyme"

http://www.fda.gov/ohrms/dockets/ac/98/transcpt/3422t1.rtf

LUFT: "The point that I wanted to make in regard to the study is that
***there is very heavy dependence on serologic confirmation***. "And
when we start thinking about the adverse events, it was stated
originally when we got the overview of the disease that the disease is
really quite protean. And actually the adverse events are very
similar to what the disease manifestations are. And if you start to,
as I think Dr. Hall was eluding to -- if you start to kind of say well
how often do you actually become sero positive, you can start to have
a different take on when someone has an adverse event of whether it is
disease specific or infection specific versus vaccine specific. And I
think that that is an important issue that we have to deal with.***"
I can only say from my own experience, having done a randomized double-
blind controlled study that was FDA approved regarding the comparison
of ezithromycin to amoxicillin, when we found that azithromycin was
not as effective as amoxicillin, those patients when they had their
disease related events were sero negative at the time that they had
those events. So the serologic criteria would not have -- they would
have done very well actually with these criteria, and I think Pfizer
would have been much happier with me than they turned out to be."

LUFT: "So I just wanted to kind of ask in regard to that, and I think
it goes back to an earlier question that I asked in regard to the self-
reported events and ***whether there was any segregation that occurred
between the 10 percent of patients reporting that they were having
symptomatology, whether there was any difference between the vaccine
group and the placebo group independent of antibody or serologic
diagnosis."***

DR. PIETRUSKO: Dr. Parenti?

DR. PARENTI (SMITHKLINE): ***"Basically the two groups [Lyme and
LYMErix-Adverse Events-- KMD]had the same suspect symptoms.*** We
didn't put it through statistical rigor, but when you looked at what
it is that people came into the office with, what complaints, there
was basically the same complaints in both groups. So both groups were
being evaluated for the same things."
http://www.fda.gov/ohrms/dockets/ac/98/transcpt/3422t1.rtf

==========================================

Hard to argue with.

The Nobels went to the peeps who
described this acquired dysimmunity,
and the US Military can't trust the
CDC, since they're a dangerous, for-profit
agency.


Remember the Kaiser Logo:
"No Antibodies, No Disease ;)"


KMDickson
http://www.actionlyme.org